ENTITY

Jiangxi Boya Bio Pharmaceutical (300294 CH)

Analysis

Health Care • China

Jiangxi Boya Bio-Pharmaceutical company Limited develops, produces and sells blood product. The Company's main products include human serum albumin, intravenous immunoglobulin (static C) and fibrinogen.

Refresh

Company Presentation • 25 Aug 2021 06:00

H1 2021

Company Presentation • 29 Mar 2022 06:00

H2 2021

Company Presentation • 25 Aug 2022 06:00

H1 2022

Company Presentation • 30 Mar 2023 06:00

H2 2022

Company Presentation • 31 Aug 2023 06:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

H1 2021

H2 2021

H1 2022

H2 2022

H1 2023